Approches de gene silencing pour le traitement de la maladie de Huntington

  • Merienne N
  • Déglon N
N/ACitations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Huntington's disease is a rare neurodegenerative disease caused by a pathologic CAG expansion in the exon 1 of the huntingtin (HTT) gene. Aggregation and abnormal function of the mutant HTT (mHTT) cause motor, cognitive and psychiatric symptoms in patients, which lead to death in 15-20 years. Currently, there is no treatment for HD. Experimental approaches based on drug, cell or gene therapy are developed and reach progressively to the clinic. Among them, mHTT silencing using small non-coding nucleic acids display important physiopathological benefit in HD experimental models.

Cite

CITATION STYLE

APA

Merienne, N., & Déglon, N. (2015). Approches de gene silencing pour le traitement de la maladie de Huntington. Médecine/Sciences, 31(2), 159–167. https://doi.org/10.1051/medsci/20153102012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free